Physician

Austin Michael Fraser, M.D.

According to 2025 Medicare claims, Austin Fraser, M.D. (NPI: 1336339118) practices rheumatology in the New Orleans-Metairie, LA market, with the plurality of this provider's patient population coming from Orleans, LA. This provider's primary affiliated billing organization is THE RHEUMATOLOGY GROUP, LLC (NPI: 1447228861; TIN: 721039795) and primary practice location at 70005-3079.

Fraser's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 167 traditional Medicare patients, billed 51,875 HCPCS/CPT codes, and received $407,881 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,331 prescription claims across 346 beneficiaries totaling $2,152,614 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 109 records totaling $2,318. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $24,354 to $407,881. Similarly, Part D prescription costs have moved sharply higher in recent years, from $204,728 to $2,152,614. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$204K$408K2015 Medicare payment: $24,354 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $77,315 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $70,573 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $83,638 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $121,385 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $328,673 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $329,035 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $282,797 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $294,913 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $407,881 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015361,366$24,354
2016456,959$77,315
2017604,565$70,573
2018626,482$83,638
20198912,040$121,385
202010726,114$328,673
202110331,378$329,035
202211432,391$282,797
202311933,031$294,913
202416751,875$407,881

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.2M2015 Drug cost: $204,728 (USD; Tot_Drug_Cst)2016 Drug cost: $387,023 (USD; Tot_Drug_Cst)2017 Drug cost: $446,376 (USD; Tot_Drug_Cst)2018 Drug cost: $447,036 (USD; Tot_Drug_Cst)2019 Drug cost: $454,500 (USD; Tot_Drug_Cst)2020 Drug cost: $874,686 (USD; Tot_Drug_Cst)2021 Drug cost: $982,683 (USD; Tot_Drug_Cst)2022 Drug cost: $959,073 (USD; Tot_Drug_Cst)2023 Drug cost: $1,375,213 (USD; Tot_Drug_Cst)2024 Drug cost: $2,152,614 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201595711$204,728
2016871,017$387,023
201799918$446,376
2018125986$447,036
20191621,072$454,500
20202361,659$874,686
20212671,887$982,683
20222671,785$959,073
20232571,830$1,375,213
20243462,331$2,152,614

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less30139$84
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more153318$80
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's7186$12
96372Injection of drug or substance under skin or into muscle2573$9
J7050Infusion, normal saline solution, 250 cc2681$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab1003,052$793,099
Enbrel SureclickEtanercept31868$264,043
RinvoqUpadacitinib31930$222,655
KevzaraSarilumab23896$141,234
Enbrel MiniEtanercept13364$112,842

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.109$2,318ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Austin Michael Fraser, M.D.?

Tedicare shows public-source Medicare data for Austin Michael Fraser, M.D. (NPI 1336339118), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Austin Michael Fraser, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Austin Michael Fraser, M.D.?

Austin Michael Fraser, M.D. is linked to THE RHEUMATOLOGY GROUP, LLC (billing NPI 1447228861) in the available physician profile data.

Does Austin Michael Fraser, M.D. have Open Payments data?

Austin Michael Fraser, M.D. has 109 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.